• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘢痕疙瘩病因及治疗的当前概念

Current concepts in the etiology and treatment of keloids.

作者信息

Naylor Michelle C, Brissett Anthony E

机构信息

Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Facial Plast Surg. 2012 Oct;28(5):504-12. doi: 10.1055/s-0032-1325644. Epub 2012 Oct 1.

DOI:10.1055/s-0032-1325644
PMID:23027217
Abstract

Keloids are benign, fibroproliferative growths that occur as a result of dermal injury in ~15% of the population. They are characterized by their extension beyond the confines of the original injury and often present with pain and pruritus. Additionally, these growths may result in cosmetic deformities and contribute to significant emotional distress. It is thought that keloids form as a result of aberrancies in the normal wound-healing process, which is complex and involves an elegant interplay between multiple cell types, cytokines, and proteins. The exact etiology is unknown, but significant research efforts have been made. These efforts have revealed that various cell types in keloids are either hyperresponsive and/or overproductive of various growth factors. Additionally, keloid cell types respond differently to mechanical strain than skin cells in patients who do not form keloids. This lack of understanding of keloid pathophysiology has left the care provider with a lack of a single definitive treatment strategy. Instead, a multitude of therapies exist ranging from surgery to injectables to lasers and any combination thereof. This purpose of this article is to highlight our current knowledge and emerging scientific understanding of keloid pathology and the current management strategies.

摘要

瘢痕疙瘩是一种良性纤维增生性肿物,约15%的人群在皮肤损伤后会出现。其特点是超出原始损伤范围生长,常伴有疼痛和瘙痒。此外,这些肿物可能导致美容缺陷,并造成严重的情绪困扰。人们认为瘢痕疙瘩是正常伤口愈合过程异常所致,该过程复杂,涉及多种细胞类型、细胞因子和蛋白质之间的精妙相互作用。确切病因尚不清楚,但已开展了大量研究工作。这些研究表明,瘢痕疙瘩中的各种细胞类型对各种生长因子反应过度和/或产生过多。此外,与不形成瘢痕疙瘩的患者相比,瘢痕疙瘩细胞类型对机械应变的反应不同。对瘢痕疙瘩病理生理学的这种缺乏了解,使得医疗服务提供者缺乏单一的明确治疗策略。相反,存在多种治疗方法,从手术到注射剂再到激光以及它们的任何组合。本文的目的是强调我们目前对瘢痕疙瘩病理学的认识以及新出现的科学理解,以及当前的管理策略。

相似文献

1
Current concepts in the etiology and treatment of keloids.瘢痕疙瘩病因及治疗的当前概念
Facial Plast Surg. 2012 Oct;28(5):504-12. doi: 10.1055/s-0032-1325644. Epub 2012 Oct 1.
2
Utilizing topical therapies and mitomycin to reduce scars.
Facial Plast Surg. 2012 Oct;28(5):513-7. doi: 10.1055/s-0032-1325645. Epub 2012 Oct 1.
3
Scars and keloids.瘢痕与瘢痕疙瘩
Dermatol Clin. 1993 Oct;11(4):697-708.
4
Hypertrophic scars and keloids.肥厚性瘢痕与瘢痕疙瘩。
Clin Podiatr Med Surg. 2001 Jan;18(1):147-59.
5
Keloids and hypertrophic scars: review and treatment strategies.瘢痕疙瘩和增生性瘢痕:综述与治疗策略
Semin Cutan Med Surg. 1999 Jun;18(2):159-71. doi: 10.1016/s1085-5629(99)80040-6.
6
Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.肥厚性瘢痕、瘢痕疙瘩和挛缩。治疗的细胞和分子基础。
Surg Clin North Am. 1997 Jun;77(3):701-30. doi: 10.1016/s0039-6109(05)70576-4.
7
Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.增生性瘢痕和瘢痕疙瘩的生物学、预防和治疗策略的最新认识。
Int J Mol Sci. 2018 Mar 2;19(3):711. doi: 10.3390/ijms19030711.
8
Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.肥厚性瘢痕和瘢痕疙瘩——关于其病理生理学、危险因素及治疗管理的综述
Dermatol Surg. 2009 Feb;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x.
9
Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?肥厚性瘢痕和瘢痕疙瘩的病理生理学见解:它们有何不同?
Adv Skin Wound Care. 2018 Jan;31(1):582-595. doi: 10.1097/01.ASW.0000527576.27489.0f.
10
Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.瘢痕疙瘩与增生性瘢痕:病理生理学、分类及治疗
Dermatol Surg. 2017 Jan;43 Suppl 1:S3-S18. doi: 10.1097/DSS.0000000000000819.

引用本文的文献

1
Increased Susceptibility to Mechanical Stretch Drives the Persistence of Keloid Fibroblasts: An Investigation Using a Stretchable PDMS Platform.对机械拉伸敏感性增加促使瘢痕疙瘩成纤维细胞持续存在:一项使用可拉伸聚二甲基硅氧烷平台的研究。
Biomedicines. 2024 Sep 24;12(10):2169. doi: 10.3390/biomedicines12102169.
2
LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.长链非编码RNA GNAS-AS1敲低通过介导miR-188-5p/RUNX2轴抑制瘢痕疙瘩细胞生长。
Mol Cell Biochem. 2023 Apr;478(4):707-719. doi: 10.1007/s11010-022-04538-6. Epub 2022 Aug 29.
3
Calcium Electroporation for Keloids: A First-in-Man Phase I Study.
钙电穿孔治疗瘢痕疙瘩:首例人体 I 期研究。
Dermatology. 2021;237(6):961-969. doi: 10.1159/000514307. Epub 2021 Mar 31.
4
Small Leucine-Rich Proteoglycans in Skin Wound Healing.皮肤伤口愈合中的小富含亮氨酸蛋白聚糖
Front Pharmacol. 2020 Jan 28;10:1649. doi: 10.3389/fphar.2019.01649. eCollection 2019.
5
Long non-coding RNA CACNA1G-AS1 promotes calcium channel protein expression and positively affects human keloid fibroblast migration.长链非编码RNA CACNA1G-AS1促进钙通道蛋白表达并对人瘢痕疙瘩成纤维细胞迁移产生积极影响。
Oncol Lett. 2018 Jul;16(1):891-897. doi: 10.3892/ol.2018.8717. Epub 2018 May 16.
6
Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target.瘢痕疙瘩组织中上皮-间质转化的检测及瘢痕疙瘩治疗靶点的可能性
Plast Reconstr Surg Glob Open. 2016 Nov 28;4(11):e1138. doi: 10.1097/GOX.0000000000001138. eCollection 2016 Nov.
7
Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.转化生长因子-β/信号转导分子Smad通路与Wnt/β-连环蛋白通路在病理性瘢痕形成中的相互作用
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7631-9. eCollection 2015.
8
[Therapy of hypertrophic scars and keloids].[肥厚性瘢痕与瘢痕疙瘩的治疗]
Hautarzt. 2014 Dec;65(12):1067-77; quiz 1078-9. doi: 10.1007/s00105-014-3546-0.
9
Models of abnormal scarring.异常瘢痕形成模型。
Biomed Res Int. 2013;2013:423147. doi: 10.1155/2013/423147. Epub 2013 Sep 3.